4-Bromo-6-chloronicotinonitrile

Catalog No.: 
ACNWFZ024
CAS No.: 
1354021-07-0
Molecular Formula: 
C6H2BrClN2
Molecular Weight: 
217.45
4-Bromo-6-chloronicotinonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$74.00In stockInquiry
100mg95%$118.00In stockInquiry
250mg95%$237.00In stockInquiry
1g95%$504.00In stockInquiry
5g95%$1517.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Bromo-6-chloronicotinonitrile
IUPAC Name4-bromo-6-chloronicotinonitrile
MDL No.MFCD21025851
Molecular FormulaC6H2BrClN2
Molecular Weight217.45
SMILESN#CC1=CN=C(Cl)C=C1Br
InChI KeySDBOUCULKBNTGZ-UHFFFAOYSA-N
Synonym3-Pyridinecarbonitrile, 4-bromo-6-chloro-;4-Bromo-6-chloronicotinonitrile;4-Bromo-6-chloro-3-pyridinecarbonitrile
CAS No.1354021-07-0
PubChem CID118839708

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACNWFZ024 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1In Stock
  4. Then
  5. ACNWFZ024 route product structure diagram
    ACNWFZ0241354021-07-0In Stock
Inquiry

2. ACNWFZ024 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1In Stock
  4. Then
  5. ACNWFZ024 route product structure diagram
    ACNWFZ0241354021-07-0In Stock
Inquiry

3. ACNWFZ024 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNWFZ024 route product structure diagram
    ACNWFZ0241354021-07-0In Stock
Inquiry

Comments (0)